Christine Brezden-Masley

Read how they describe their research on their University of Toronto profile.

• Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HR+/HER2− Metastatic Breast Cancer 2025

  Current Oncology · 2026

• A Consensus Approach to the Incorporation of Total Neoadjuvant Therapy in a Treatment Algorithm for Stage I-III Resectable Rectal Cancer.

  Current oncology (Toronto, Ont.) · 2026

• Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with Triple Negative Breast Cancer in Both the Early and Metastatic Setting 2025

  Current Oncology · 2026

• A type 1 hybrid effectiveness-implementation trial of a virtual exercise-based rehabilitation intervention for persistent chemotherapy induced peripheral neuropathy (EX-CIPN).

  CIHR · 2026 · Co-investigator

  $753,525

• The JUdicious Surveillance for Trastuzumab Induced Cardiotoxicity in the First Year (JUSTIFY) Randomized Controlled Trial

  CIHR · 2025 · Co-investigator

  $1,487,925

• A pragmatic randomized controlled trial of a virtual exercise-based rehabilitation intervention for persistent chemotherapy-induced peripheral neuropathy (EX-CIPN).

  CIHR · 2025 · Co-investigator

  $100,000